XETRA - Delayed Quote EUR

MeVis Medical Solutions AG (M3V.DE)

Compare
26.00
0.00
(0.00%)
As of April 2 at 5:36:19 PM GMT+2. Market Open.
Loading Chart for M3V.DE
  • Previous Close 26.00
  • Open 26.00
  • Bid 25.80 x 60000
  • Ask 26.20 x 60000
  • Day's Range 26.00 - 26.00
  • 52 Week Range 22.80 - 26.80
  • Volume 507
  • Avg. Volume 59
  • Market Cap (intraday) 47.32M
  • Beta (5Y Monthly) -0.10
  • PE Ratio (TTM)
  • EPS (TTM) 0.00
  • Earnings Date May 27, 2025
  • Forward Dividend & Yield 0.95 (3.65%)
  • Ex-Dividend Date Mar 26, 2025
  • 1y Target Est --

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, it develops and sells software licenses; and provides services for technical visualization and online training. The company was incorporated in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.

www.mevis.de

100

Full Time Employees

September 30

Fiscal Year Ends

Recent News: M3V.DE

View More

Performance Overview: M3V.DE

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

M3V.DE
8.72%
DAX P (^GDAXI)
9.57%

1-Year Return

M3V.DE
9.61%
DAX P (^GDAXI)
18.76%

3-Year Return

M3V.DE
16.47%
DAX P (^GDAXI)
51.00%

5-Year Return

M3V.DE
4.36%
DAX P (^GDAXI)
129.00%

Compare To: M3V.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: M3V.DE

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    47.32M

  • Enterprise Value

    40.79M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.79

  • Price/Book (mrq)

    2.65

  • Enterprise Value/Revenue

    2.40

  • Enterprise Value/EBITDA

    8.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.87%

  • Return on Assets (ttm)

    9.13%

  • Return on Equity (ttm)

    25.58%

  • Revenue (ttm)

    16.97M

  • Net Income Avi to Common (ttm)

    4.56M

  • Diluted EPS (ttm)

    0.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.53M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.43M

Research Analysis: M3V.DE

View More

Company Insights: M3V.DE

Research Reports: M3V.DE

View More

People Also Watch